Abstract
Rapid human immunodeficiency virus (HIV) testing for the management of occupational exposure of healthcare workers significantly decreased the number of anti-retroviral post-exposure prophylaxis regimens started whilst awaiting HIV test results. The study confirmed an equivalent performance of the rapid test in comparison with HIV enzyme immunoassay, and suggests it is cost-effective. In addition, two other potential benefits emerged: reducing the number of source patients who remain untested and increasing the number of occupational exposures reported.
Copyright 2004 The Hospital Infection Society
Publication types
-
Comparative Study
-
Evaluation Study
-
Research Support, Non-U.S. Gov't
MeSH terms
-
AIDS Serodiagnosis / economics
-
AIDS Serodiagnosis / methods*
-
Anti-HIV Agents / economics
-
Anti-HIV Agents / therapeutic use
-
Antiretroviral Therapy, Highly Active / economics
-
Antiretroviral Therapy, Highly Active / statistics & numerical data
-
Blood-Borne Pathogens / isolation & purification*
-
Chemoprevention / statistics & numerical data
-
Diagnostic Tests, Routine* / classification
-
Diagnostic Tests, Routine* / economics
-
HIV Infections / diagnosis*
-
HIV Infections / enzymology
-
HIV Infections / prevention & control
-
Health Personnel
-
Humans
-
Immunoenzyme Techniques / economics
-
Immunoenzyme Techniques / methods*
-
Infectious Disease Transmission, Patient-to-Professional / prevention & control
-
Italy
-
Lamivudine / economics
-
Lamivudine / therapeutic use
-
Occupational Exposure / adverse effects
-
Occupational Exposure / analysis*
-
Pilot Projects
-
Zidovudine / economics
-
Zidovudine / therapeutic use
Substances
-
Anti-HIV Agents
-
Lamivudine
-
Zidovudine